CS268191B2 - Method of new 4,5-dihydrooxazole derivatives production - Google Patents

Method of new 4,5-dihydrooxazole derivatives production Download PDF

Info

Publication number
CS268191B2
CS268191B2 CS876497A CS649787A CS268191B2 CS 268191 B2 CS268191 B2 CS 268191B2 CS 876497 A CS876497 A CS 876497A CS 649787 A CS649787 A CS 649787A CS 268191 B2 CS268191 B2 CS 268191B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
mmol
hydrogen
oxazolyl
Prior art date
Application number
CS876497A
Other languages
Czech (cs)
English (en)
Other versions
CS649787A2 (en
Inventor
Dieter Dr Binder
Franz Dipl Ing Rovenszky
Hubert Peter Dr Ferber
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of CS649787A2 publication Critical patent/CS649787A2/cs
Publication of CS268191B2 publication Critical patent/CS268191B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
CS876497A 1986-09-10 1987-09-08 Method of new 4,5-dihydrooxazole derivatives production CS268191B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243786 1986-09-10

Publications (2)

Publication Number Publication Date
CS649787A2 CS649787A2 (en) 1989-05-12
CS268191B2 true CS268191B2 (en) 1990-03-14

Family

ID=3534337

Family Applications (1)

Application Number Title Priority Date Filing Date
CS876497A CS268191B2 (en) 1986-09-10 1987-09-08 Method of new 4,5-dihydrooxazole derivatives production

Country Status (21)

Country Link
US (1) US4818760A (fr)
EP (1) EP0261478B1 (fr)
JP (1) JPS6377878A (fr)
KR (1) KR880003941A (fr)
AT (1) ATE62908T1 (fr)
AU (1) AU596869B2 (fr)
CA (1) CA1256109A (fr)
CS (1) CS268191B2 (fr)
DD (1) DD262230A5 (fr)
DE (1) DE3769563D1 (fr)
DK (1) DK165322C (fr)
ES (1) ES2028838T3 (fr)
FI (1) FI89267C (fr)
GR (1) GR3001842T3 (fr)
HU (1) HU198059B (fr)
MY (1) MY102003A (fr)
NO (1) NO165195C (fr)
NZ (1) NZ221723A (fr)
SG (1) SG39892G (fr)
SU (1) SU1574177A3 (fr)
ZA (1) ZA876740B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983263A1 (fr) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2000074654A1 (fr) 1999-06-07 2000-12-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
AU2005239838B2 (en) * 2004-05-07 2011-08-11 Takeda Gmbh Pharmaceutical dosage form comprising pellets as well as its manufacturing process
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (fr) * 2006-04-03 2014-03-11 Isa Odidi Dispositif d'administration a liberation commandee comprenant un enrobage organosol
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
EP0234485B1 (fr) * 1986-02-20 1992-04-01 Hoechst Aktiengesellschaft Dérivés substitués du thiénoimidazole, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur application comme inhibiteurs de la sécrétion du suc gastrique

Also Published As

Publication number Publication date
JPS6377878A (ja) 1988-04-08
EP0261478B1 (fr) 1991-04-24
FI89267B (fi) 1993-05-31
DK165322C (da) 1993-03-29
SU1574177A3 (ru) 1990-06-23
CA1256109A (fr) 1989-06-20
DD262230A5 (de) 1988-11-23
NO165195C (no) 1991-01-09
HUT47288A (en) 1989-02-28
HU198059B (en) 1989-07-28
ES2028838T3 (es) 1992-07-16
MY102003A (en) 1992-02-29
NZ221723A (en) 1989-11-28
NO873722D0 (no) 1987-09-07
GR3001842T3 (en) 1992-11-23
DK469687A (da) 1988-03-11
FI873892A0 (fi) 1987-09-09
NO873722L (no) 1988-03-11
ZA876740B (en) 1988-03-14
KR880003941A (ko) 1988-05-31
CS649787A2 (en) 1989-05-12
DK165322B (da) 1992-11-09
AU7817087A (en) 1988-03-17
EP0261478A1 (fr) 1988-03-30
US4818760A (en) 1989-04-04
FI89267C (fi) 1993-09-10
ATE62908T1 (de) 1991-05-15
FI873892A (fi) 1988-03-11
SG39892G (en) 1992-10-02
AU596869B2 (en) 1990-05-17
NO165195B (no) 1990-10-01
DK469687D0 (da) 1987-09-09
DE3769563D1 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
US4472409A (en) 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
US4248880A (en) Treatment of gastric ulcers with naphthimidazole derivatives
DK150510B (da) Analogifremgangsmaade til fremstilling af substituerede 2-(2-benzimidazolyl)-pyridiner eller terapeutisk acceptable salte deraf
CH665417A5 (fr) Derives du benzimidazole, procede pour leur preparation et agents anti-ulceres contenant ces derives.
NZ208023A (en) Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions
CS268191B2 (en) Method of new 4,5-dihydrooxazole derivatives production
EP0283504A1 (fr) Composes
JPH03388B2 (fr)
NO861802L (no) Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling.
KR900004828B1 (ko) 페닐-나프티리딘의 제조방법
US5037830A (en) Novel thiouracyl derivatives, pharmaceutical compositions containing them and process for preparing same
EP0354788A1 (fr) Dérivés d'imidazole
FR2576900A1 (fr) Derives de cyclohepto-imidazole 2-substitue, agents anti-ulcereux et procede pour leur preparation
JP2794640B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP2816974B2 (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
EP0452076B1 (fr) Dérivés de thiazole et d'imidazole et compositions anti-ulcères les contenant
CS264298B2 (cs) Způsob výroby dusíkatých arylmethoxythiofenových derivátů
JPS61221175A (ja) ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
KR810000633B1 (ko) 이미다졸 유도체의 제조방법
FR2640975A1 (fr)
JPH0430953B2 (fr)
JPH03223260A (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPH037279A (ja) ２―チオピランカルボチオアミド誘導体
LU83322A1 (fr) 6-(pyridinyl)-3(2h)-pyridazinones 4-substitutees,leur preparation,leur utilisation comme agents cardiotoniques,et composes intermediaires.
JPH046713B2 (fr)